{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:25:26Z","timestamp":1793856326944,"version":"4.6.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00415-026-14168-3","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:42:20Z","timestamp":1790574140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Progressive motor impairment from intracerebral critical demyelinating lesions"],"prefix":"10.1007","volume":"273","author":[{"given":"Purnashree","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin P.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Oliver","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Albites","family":"Coen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia F.","family":"Lucchinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Weinshenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhun H.","family":"Kantarci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2880-935X","authenticated-orcid":false,"given":"B. Mark","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"issue":"2","key":"14168_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","volume":"378","author":"DS Reich","year":"2018","unstructured":"Reich DS, Lucchinetti CF, Calabresi PA (2018) Multiple sclerosis. N Engl J Med 378(2):169\u2013180. https:\/\/doi.org\/10.1056\/NEJMra1401483","journal-title":"N Engl J Med"},{"key":"14168_CR2","first-page":"119","volume-title":"Handbook of clinical neurology","author":"DS Younger","year":"2023","unstructured":"Younger DS (2023) Chapter 6 - Multiple sclerosis: motor dysfunction. In: Younger DS (ed) Handbook of clinical neurology. Elsevier, pp 119\u2013147"},{"issue":"1","key":"14168_CR3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","volume":"22","author":"T Kuhlmann","year":"2023","unstructured":"Kuhlmann T, Moccia M, Coetzee T et al (2023) Multiple sclerosis progression: time for a new mechanism-driven framework. Lancet Neurol 22(1):78\u201388. https:\/\/doi.org\/10.1016\/S1474-4422(22)00289-7","journal-title":"Lancet Neurol"},{"issue":"9","key":"14168_CR4","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1093\/brain\/awac016","volume":"145","author":"FD Lublin","year":"2022","unstructured":"Lublin FD, H\u00e4ring DA, Ganjgahi H et al (2022) How patients with multiple sclerosis acquire disability. Brain 145(9):3147\u20133161. https:\/\/doi.org\/10.1093\/brain\/awac016","journal-title":"Brain"},{"issue":"3","key":"14168_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/ana.25808","volume":"88","author":"M Filippi","year":"2020","unstructured":"Filippi M, Preziosa P, Langdon D et al (2020) Identifying progression in multiple sclerosis: new perspectives. Ann Neurol 88(3):438\u2013452. https:\/\/doi.org\/10.1002\/ana.25808","journal-title":"Ann Neurol"},{"key":"14168_CR6","doi-asserted-by":"publisher","first-page":"106674","DOI":"10.1016\/j.msard.2025.106674","volume":"103","author":"LR Sol\u00eds-Tarazona","year":"2025","unstructured":"Sol\u00eds-Tarazona LR, Molina-Casta\u00f1o M, Barea-Moya L, Galan J, Raket LL, Gil-Perotin S (2025) A systematic review and meta-analysis of real-world data predictors for conversion to progressive multiple sclerosis. Mult Scler Relat Disord 103:106674. https:\/\/doi.org\/10.1016\/j.msard.2025.106674","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"14168_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/00019052-200206000-00003","volume":"15","author":"F Barkhof","year":"2002","unstructured":"Barkhof F (2002) The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 15(3):239\u2013245. https:\/\/doi.org\/10.1097\/00019052-200206000-00003","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"14168_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-12977-6","volume":"272","author":"A Ojha","year":"2025","unstructured":"Ojha A, Tommasin S, Piervincenzi C et al (2025) Clinical and MRI features contributing to the clinico-radiological dissociation in a large cohort of people with multiple sclerosis. J Neurol 272(5):327. https:\/\/doi.org\/10.1007\/s00415-025-12977-6","journal-title":"J Neurol"},{"issue":"5","key":"14168_CR9","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1017\/cjn.2016.253","volume":"43","author":"TA Hardy","year":"2016","unstructured":"Hardy TA, Wang C, Beadnall HN et al (2016) Wallerian degeneration in the corticospinal tract following tumefactive demyelination: conventional and advanced magnetic resonance imaging. Can J Neurol Sci 43(5):726\u2013727. https:\/\/doi.org\/10.1017\/cjn.2016.253","journal-title":"Can J Neurol Sci"},{"issue":"9","key":"14168_CR10","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/acn3.51844","volume":"10","author":"M Fereidan-Esfahani","year":"2023","unstructured":"Fereidan-Esfahani M, Decker PA, Weigand SD et al (2023) Defining the natural history of tumefactive demyelination: a retrospective cohort of 257 patients. Ann Clin Transl Neurol 10(9):1544\u20131555. https:\/\/doi.org\/10.1002\/acn3.51844","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"14168_CR11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1177\/1352458520940983","volume":"27","author":"RM Kassa","year":"2021","unstructured":"Kassa RM, Sechi E, Flanagan EP et al (2021) Onset of progressive motor impairment in patients with critical central nervous system demyelinating lesions. Mult Scler 27(6):895\u2013902. https:\/\/doi.org\/10.1177\/1352458520940983","journal-title":"Mult Scler"},{"issue":"1","key":"14168_CR12","doi-asserted-by":"publisher","DOI":"10.1177\/20552173211052159","volume":"8","author":"B Barakat","year":"2022","unstructured":"Barakat B, Messina S, Nayak S et al (2022) Cerebrospinal fluid evaluation in patients with progressive motor impairment due to critical central nervous system demyelinating lesions. Mult Scler J Exp Transl Clin 8(1):20552173211052159. https:\/\/doi.org\/10.1177\/20552173211052159","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"16","key":"14168_CR13","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1212\/wnl.0000000000003235","volume":"87","author":"BM Keegan","year":"2016","unstructured":"Keegan BM, Kaufmann TJ, Weinshenker BG et al (2016) Progressive solitary sclerosis: gradual motor impairment from a single CNS demyelinating lesion. Neurology 87(16):1713\u20131719. https:\/\/doi.org\/10.1212\/wnl.0000000000003235","journal-title":"Neurology"},{"issue":"11","key":"14168_CR14","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1177\/1352458518781979","volume":"24","author":"BM Keegan","year":"2018","unstructured":"Keegan BM, Kaufmann TJ, Weinshenker BG et al (2018) Progressive motor impairment from a critically located lesion in highly restricted CNS-demyelinating disease. Mult Scler 24(11):1445\u20131452. https:\/\/doi.org\/10.1177\/1352458518781979","journal-title":"Mult Scler"},{"issue":"10","key":"14168_CR15","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00415-025-13322-7","volume":"272","author":"R Ahmed","year":"2025","unstructured":"Ahmed R, Jackson-Tarlton CS, Flanagan EP et al (2025) Critical demyelinating lesions in progressive multiple sclerosis: a prospective observational study. J Neurol 272(10):677. https:\/\/doi.org\/10.1007\/s00415-025-13322-7","journal-title":"J Neurol"},{"issue":"7","key":"14168_CR16","doi-asserted-by":"publisher","first-page":"e628","DOI":"10.1212\/wnl.0000000000007944","volume":"93","author":"E Sechi","year":"2019","unstructured":"Sechi E, Keegan BM, Kaufmann TJ, Kantarci OH, Weinshenker BG, Flanagan EP (2019) Unilateral motor progression in MS: association with a critical corticospinal tract lesion. Neurology 93(7):e628\u2013e634. https:\/\/doi.org\/10.1212\/wnl.0000000000007944","journal-title":"Neurology"},{"issue":"1","key":"14168_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1177\/13524585221114438","volume":"29","author":"CS Jackson-Tarlton","year":"2023","unstructured":"Jackson-Tarlton CS, Flanagan EP, Messina SA et al (2023) Progressive motor impairment from \u201ccritical\u201d demyelinating lesions of the cervicomedullary junction. Mult Scler 29(1):74\u201380. https:\/\/doi.org\/10.1177\/13524585221114438","journal-title":"Mult Scler"},{"issue":"6","key":"14168_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae395","volume":"6","author":"BM Keegan","year":"2024","unstructured":"Keegan BM, Absinta M, Cohen-Adad J et al (2024) Spinal cord evaluation in multiple sclerosis: clinical and radiological associations, present and future. Brain Commun 6(6):fcae395. https:\/\/doi.org\/10.1093\/braincomms\/fcae395","journal-title":"Brain Commun"},{"issue":"4","key":"14168_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0025-6196(12)61905-3","volume":"62","author":"E Kokmen","year":"1987","unstructured":"Kokmen E, Naessens JM, Offord KP (1987) A short test of mental status: description and preliminary results. Mayo Clinic Proc 62(4):281\u2013288. https:\/\/doi.org\/10.1016\/S0025-6196(12)61905-3","journal-title":"Mayo Clinic Proc"},{"key":"14168_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2025.106318","volume":"95","author":"SA Banks","year":"2025","unstructured":"Banks SA, Klassen BT, Bower JH et al (2025) Progressive unilateral tremor associated with large confluent perirolandic juxtacortical lesions in multiple sclerosis. Mult Scler Relat Disord 95:106318. https:\/\/doi.org\/10.1016\/j.msard.2025.106318","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"14168_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"issue":"10","key":"14168_CR22","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","volume":"24","author":"X Montalban","year":"2024","unstructured":"Montalban X, Lebrun-Fr\u00e9nay C, Oh J et al (2024) Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol 24(10):850\u2013865. https:\/\/doi.org\/10.1016\/S1474-4422(25)00270-4","journal-title":"Lancet Neurol"},{"issue":"5","key":"14168_CR23","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/ana.24163","volume":"75","author":"I Metz","year":"2014","unstructured":"Metz I, Weigand SD, Popescu BF et al (2014) Pathologic heterogeneity persists in early active multiple sclerosis lesions. Ann Neurol 75(5):728\u2013738. https:\/\/doi.org\/10.1002\/ana.24163","journal-title":"Ann Neurol"},{"key":"14168_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25168751","author":"I Sempik","year":"2024","unstructured":"Sempik I, Dziadkowiak E, Moreira H, Zimny A, Pokryszko-Dragan A (2024) Primary progressive multiple sclerosis-a key to understanding and managing disease progression. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25168751","journal-title":"Int J Mol Sci"},{"key":"14168_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2023.578268","volume":"387","author":"M-E Baeva","year":"2024","unstructured":"Baeva M-E, Tottenham I, Koch M, Camara-Lemarroy C (2024) Biomarkers of disability worsening in inactive primary progressive multiple sclerosis. J Neuroimmunol 387:578268. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578268","journal-title":"J Neuroimmunol"},{"issue":"4","key":"14168_CR26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1177\/13524585211031801","volume":"28","author":"MW Koch","year":"2022","unstructured":"Koch MW, Mostert J, Repovic P et al (2022) MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis. Mult Scler 28(4):561\u2013572. https:\/\/doi.org\/10.1177\/13524585211031801","journal-title":"Mult Scler"},{"issue":"6","key":"14168_CR27","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200299","volume":"11","author":"A Cagol","year":"2024","unstructured":"Cagol A, Ocampo-Pineda M, Lu P-J et al (2024) Advanced quantitative MRI unveils microstructural thalamic changes reflecting disease progression in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 11(6):e200299. https:\/\/doi.org\/10.1212\/NXI.0000000000200299","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"14168_CR28","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000279","volume":"3","author":"SC Krieger","year":"2016","unstructured":"Krieger SC, Cook K, De Nino S, Fletcher M (2016) The topographical model of multiple sclerosis: a dynamic visualization of disease course. Neurol Neuroimmunol Neuroinflamm 3(5):e279. https:\/\/doi.org\/10.1212\/nxi.0000000000000279","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"14168_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ncl.2017.08.003","volume":"36","author":"SC Krieger","year":"2018","unstructured":"Krieger SC, Sumowski J (2018) New insights into multiple sclerosis clinical course from the topographical model and functional reserve. Neurol Clin 36(1):13\u201325. https:\/\/doi.org\/10.1016\/j.ncl.2017.08.003","journal-title":"Neurol Clin"},{"key":"14168_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2025.110549","volume":"423","author":"P Boyne","year":"2025","unstructured":"Boyne P, Williamson B, Buclez J, Cramer SC, Lin DJ (2025) Probabilistic normative maps of the corticospinal and cortico-reticulospinal tracts in streamline and volumetric formats. J Neurosci Methods 423:110549. https:\/\/doi.org\/10.1016\/j.jneumeth.2025.110549","journal-title":"J Neurosci Methods"},{"key":"14168_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104614","volume":"73","author":"CS Jackson-Tarlton","year":"2023","unstructured":"Jackson-Tarlton CS, Keegan BM, Fereidan-Esfahani M et al (2023) Spinal cord and brain corticospinal tract lesions are associated with motor progression in tumefactive multiple sclerosis. Mult Scler Relat Disord 73:104614. https:\/\/doi.org\/10.1016\/j.msard.2023.104614","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"14168_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00401-016-1653-y","volume":"133","author":"T Kuhlmann","year":"2017","unstructured":"Kuhlmann T, Ludwin S, Prat A, Antel J, Br\u00fcck W, Lassmann H (2017) An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol 133(1):13\u201324. https:\/\/doi.org\/10.1007\/s00401-016-1653-y","journal-title":"Acta Neuropathol"},{"issue":"7","key":"14168_CR33","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3174\/ajnr.A8304","volume":"45","author":"BM Keegan","year":"2024","unstructured":"Keegan BM, Messina SA, Hanson D et al (2024) MR imaging features of critical spinal demyelinating lesions associated with progressive motor impairment. AJNR Am J Neuroradiol 45(7):943\u2013950. https:\/\/doi.org\/10.3174\/ajnr.A8304","journal-title":"AJNR Am J Neuroradiol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14168-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14168-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14168-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:46:35Z","timestamp":1793853995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14168-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["14168"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-14168-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"15 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Purnashree Chowdhury has nothing to disclose. Dr. Eoin P. Flanagan has served on advisory boards for Alexion, Genentech, Horizon Therapeutics and UCB. He has received research support and funding from UCB, Roche and Merck. He received royalties from UpToDate. Dr. Flanagan is a site principal investigator in a randomized clinical trial of Rozanolixizumab for relapsing myelin oligodendrocyte glycoprotein antibody-associated disease run by UCB. Dr. Flanagan is a site principal investigator and a member of the steering committee for a clinical trial of satralizumab for relapsing myelin oligodendrocyte glycoprotein antibody-associated disease run by Roche\/Genentech. Dr. Flanagan is a Co-Investigator on a study of ravulizumab for neuromyelitis optica spectrum disorder run by Alexion. Dr. Flanagan has given educational talks on neuromyelitis optica spectrum disorder funded by Alexion. Dr. Flanagan has received funding from the NIH (R01NS113828). Dr. Flanagan has received\u00a0honoraria for editing and writing articles for The Continuum Lifelong Learning in Neurology Journal which is a publication of the American Academy of Neurology.\u00a0Dr. Flanagan is a member of the medical advisory board of the MOG project and Sumaira Foundation. Dr. Flanagan is an editorial board member of Neurology, Neurology, Neuroimmunology and Neuroinflammation, The Journal of the Neurological Sciences and Neuroimmunology Reports. A patent has been submitted on DACH1-IgG as a biomarker of paraneoplastic autoimmunity. Dr. Yong Guo has nothing to disclose. Dr. W. Oliver Tobin has received research grant funding from the National Institutes of Health, the Mayo Clinic Center for MS and Autoimmune Neurology and book royalties from the publication of Mayo Clinic Cases in Neuroimmunology (Mayo Clinic Scientific Press) 2022. Dr. Bianca Albites Coen has nothing to disclose. Dr. B. Weinshenker received payments for serving as chair of a data safety monitoring committee for Zenas BioPharma and attack adjudication committees for Alexion, Medimmune,\u00a0VielaBio\/Horizon Therapeutics, and UCB Biosciences. He has consulted with Genentech, Roche, regarding clinical trial designs for neuromyelitis optica spectrum disorders. He has a patent for NMO-IgG for diagnosis of neuromyelitis optica, with royalties paid by Hospice Civil de Lyon, MVZ PD Dr. Volkmann und\u00a0Kollegen\u00a0GbR, Oxford University and RSR Limited. Dr. B. Mark Keegan, consulting EMD Serono, Tr1X, Inc, Moderna, royalties Oxford University Press Mayo Clinic Cases in Neuroimmunology.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"629"}}